Quality and Safety
The session provides instruction on ensuring quality and safety in radiopharmaceutical programs. There are many unique considerations for quality assurance in radiopharmaceutical therapy, such as workflow checklists for treatment delivery and post-treatment dosimetry. Further, responses to medical emergencies require special planning to prevent contamination of the clinic and emergency response personnel.
Topics
- Principles of Patient-Centered Clinical Radiopharmaceutical Therapy: Quality and Safety - Hyun Kim, MD
Target Audience
This activity is designed to meet the interests of radiation oncologists, radiation physicists, radiation therapists and radiation oncology residents.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Explain the purpose and content of checklists in radiopharmaceutical therapy delivery.
- Articulate the instrumentation, mathematics, and radiation protection measures necessary for the safe and effective use.
- Explain the unique considerations for medical emergency response during radiopharmaceutical delivery.
- Hyun Kim, MD, is employed by Washington University School of Medicine in St. Louis. Dr. Kim receives grant/research funding from Varian and ViewRay. Dr. Kim receives compensation from Novartis. Dr. Kim is the Founder/CEO of GlobalART. Dr. Kim is Associate Editor of IJROBP.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.